Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06146231 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Motiva Flora® Aesthetic Breast Recon® Clinical Study

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 26, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion date: Apr 2024 to Apr 2026v3
  2. Study title expanded, about 2 wordsv2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The present study will be based on a hybrid breast reconstruction approach with initial skin expansion using the Motiva Flora® Tissue Expander followed by a serial fat grafting session and a final step that includes the placement of a permanent breast implant Ergonomix2®.
Trial Details
NCT Number NCT06146231
Lead Sponsor Establishment Labs
Collaborators: NAMSA
Conditions
(from sponsor)		 Mammaplasty, Breast Cancer, Poland Syndrome
Related terms Breast Neoplasms, Poland Syndrome
Enrollment 66 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov